Wisconsin Partnership Program to support community vaccination efforts
Read the full article at:
https://www.med.wisc.edu/news-and-events/2021/february/wpp-to-support-community-vaccination-efforts/
Vaccine
UW researchers develop tool to equitably distribute limited vaccines
The School of Medicine and Public Health and UW Health have developed a tool that incorporates age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.
Read the full article at: https://news.wisc.edu/uw-researchers-develop-tool-to-equitably-distribute-limited-vaccines/Vaccine arrives at UW Health
UW Health received its first doses of the Pfizer COVID-19 vaccine the morning of Monday, Dec. 14. By early afternoon, the first doses were given to frontline medical personnel.
Read the full article at: https://news.wisc.edu/vaccine-arrives-at-uw-health/Preparing for the vaccine
In anticipation of the arrival of COVID-19 vaccines, UW Health is training staff to administer them to tier 1A front-line healthcare workers. Nurses, nursing assistants, clinical techs and others are being trained to prepare the vials of vaccines and administer them. To master injecting the vaccines, they will first practice by injecting colleagues (and sometimes […]
Read the full article at: https://news.wisc.edu/preparing-for-the-vaccine/New vaccine strategy harnesses ‘foot soldier’ T-cells to provide protection against influenza, other coronaviruses
Researchers believe the same approach can be applied to several other respiratory pathogens, including the novel coronavirus that causes COVID-19.
Read the full article at: https://news.wisc.edu/new-vaccine-strategy-harnesses-foot-soldier-t-cells-to-provide-protection-against-influenza/Waisman Biomanufacturing partners with GigaGen to manufacture new COVID-19 drug
The drug, called GIGA-2050, uses a new approach similar to treating COVID-19 patients with convalescent plasma.
Read the full article at: https://news.wisc.edu/waisman-biomanufacturing-partners-with-gigagen-to-manufacture-new-covid-19-drug/UW Health and University of Wisconsin selected as one of first clinical sites in the U.S. to test new COVID-19 vaccine
Read the full article at:
https://www.med.wisc.edu/news-and-events/2020/august/uw-uw-health-selected-for-covid-19-vaccine-trials/
Waisman Biomanufacturing partners with Heat Biologics to manufacture COVID-19 vaccine
The vaccine will target those most vulnerable to COVID-19 — namely, the elderly and those with health conditions that weaken their immune system. Phase 1 trials could begin in early 2021 and UW–Madison may be a trial site.
Read the full article at: https://news.wisc.edu/72318-2/UW–Madison, FluGen, Bharat Biotech collaborate to develop coronavirus vaccine
An international collaboration of virologists at the University of Wisconsin–Madison and the vaccine companies FluGen and Bharat Biotech has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu. CoroFlu will build …
Read the full article at: https://obe.wisc.edu/news/uw-madison-flugen-bharat-biotech-collaborate-to-develop-coronavirus-vaccine